Laarman G J, Serruys P W, Verzijlbergen J F, Ascoop C A
Department of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
Eur Heart J. 1990 Aug;11(8):705-11. doi: 10.1093/oxfordjournals.eurheartj.a059785.
Intravenous dipyridamole thallium testing is a useful alternative procedure for assessing coronary artery disease (CAD) in patients who are unable to perform maximal exercise tests. Ischaemic ST segment depression and angina pectoris are frequently observed during the test, in particular when exercise is added to dipyridamole infusion. To establish the clinical significance and additional diagnostic value of these markers of ischaemia during dipyridamole low-level exercise testing (DXT) 57 patients with CAD (group A), 21 patients with normal or near-normal coronary arteries at coronary arteriography (group B), and 20 healthy subjects with low likelihood of CAD (group C) were studied. During DXT ischaemic ST segment depression was observed in 28 patients (47%) of group A and in two patients (10%) of group B. Angina pectoris was experienced by 35 patients (61%) of group A and by five patients (24%) of group B. The positive predictive value of both ST depression and angina pectoris was high (88 and 93%, respectively), but the negative predictive values were low (42 and 40%, respectively). Combining ST segment analysis with the findings of thallium imaging significantly increased the diagnostic accuracy of the test. ST segment depression, angina pectoris, and thallium abnormalities were highly specific findings if the study population consisted of asymptomatic subjects with a low likelihood of CAD (group C). Sensitivity for the detection of the presence of CAD increased with the extent of CAD for all parameters studied. Thus, ST depression and angina pectoris, alone or in combination, during DXT have little diagnostic significance, although sensitivity is increased in patients with triple-vessel CAD.(ABSTRACT TRUNCATED AT 250 WORDS)
对于无法进行最大运动试验的患者,静脉注射双嘧达莫心肌灌注显像检查是评估冠状动脉疾病(CAD)的一种有用的替代方法。在检查过程中经常观察到缺血性ST段压低和心绞痛,尤其是在双嘧达莫输注时加做运动的情况下。为了确定双嘧达莫低水平运动试验(DXT)期间这些缺血标志物的临床意义和额外诊断价值,对57例CAD患者(A组)、21例冠状动脉造影显示冠状动脉正常或接近正常的患者(B组)和20例CAD可能性低的健康受试者(C组)进行了研究。在DXT期间,A组28例患者(47%)和B组2例患者(10%)观察到缺血性ST段压低。A组35例患者(61%)和B组5例患者(24%)经历了心绞痛。ST段压低和心绞痛的阳性预测值都很高(分别为88%和93%),但阴性预测值很低(分别为42%和40%)。将ST段分析与铊显像结果相结合显著提高了检查的诊断准确性。如果研究人群为CAD可能性低的无症状受试者(C组),ST段压低、心绞痛和铊异常是高度特异性的表现。对于所有研究参数,CAD存在的检测敏感性随CAD程度增加而增加。因此,DXT期间单独或联合出现的ST段压低和心绞痛诊断意义不大,尽管三支血管CAD患者的敏感性有所增加。(摘要截短至250字)